Funding · Company
Mediar Therapeutics, Inc.
Boston, MABiotech & Pharma
Mediar Therapeutics, Inc. of Boston, MA has disclosed $123M across 2 Form D offerings filed with the SEC between Oct 22, 2024 and Dec 23, 2025.
$123M
Total disclosed
2
Form D offerings
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$38M
Form D · Dec 23, 2025 ↗
Q4 2025
· target $76M
$85M
Form D · Oct 22, 2024 ↗
Q4 2024
· 2 amendments, first filed Dec 2, 2022
Filing details
HeadquartersBoston, MAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001766784Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. Spot an error? Full methodology →